Friday, May 13, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Researchers discover a new function of anti-HIV-1 antibodies

by Medical Finance
in News
CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.
9
SHARES
105
VIEWS
Share on FacebookShare on Twitter

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures. The scientists found that certain antibodies already known for effectively targeting HIV-1 envelope (Env) protein can prevent infected cells from releasing viral particles, thus halting viral spread. The antibodies are Y-shaped, enabling them to attach themselves between the infected cell and viral particles or directly between viral particles. This chain composed of antibodies and viral particles prevents viral spread. These findings demonstrate that these powerful antibodies exhibit different antiviral activities in addition to neutralization. The study is published in the February 2, 2022 issue of Nature Communications.

Broadly neutralizing antibodies (bNAbs) targeting virus envelope (Env) protein have significant potential for treating HIV-1. They were initially identified in rare cases of patients whose serum was capable of inhibiting numerous HIV strains. These antibodies exhibit multiple antiviral activities. As well as neutralizing the virus, i.e. preventing it from infecting new cells, they also kill infected cells. Consequently, they are referred to as polyfunctional molecules. It is necessary to fully understand the scope of these antiviral activities in order to use existing antibodies more effectively or refine the selection criteria for new antibodies. It is moreover useful to further investigate the polyfunctionality of anti-HIV-1 antibodies in order to improve our understanding of the role played by antibodies and thus tackle other viral infections.

Initially, teams at the Institut Pasteur, CNRS, VRI and Université de Paris sought to determine whether antibodies were capable of preventing infected cells from producing viral particles. To that end, they cultured CD4 T cells (HIV’s natural target) in vitro with various antibodies for 24 hours. They subsequently measured the quantity of viral particles produced by the cells in the culture medium and the quantity of viral particles remaining in the cells. As a result of these experiments, the scientists were able to demonstrate that certain antibodies increased virus quantity in cells but reduced it in the culture medium. This intriguing finding led them to believe that certain antibodies impeded the release of viral particles without preventing their production.

To test this theory, the scientists used various microscopy techniques to observe cells’ production of viral particles. They initially examined the cells by fluorescence microscopy, a technique used to differentiate virus proteins. This enabled them to demonstrate that infected cells accumulate large quantities of mature viral protein. This finding suggests that full viral particles accumulate in cells. To determine the precise location of these viral particles, the scientists subsequently used scanning electron microscopy to observe the surface of infected cells. “Using this method, we observed that these antibodies (bNAbs) prompt an accumulation of viral particles at the surface of cells, forming clusters and highly atypical structures (see illustration),” comments Timothée Bruel, co-last author of the study and scientist in the Virus and Immunity Unit at the Institut Pasteur.

Next, the scientists combined a transmission electron microscopy technique with immunogold labeling. This enabled them to demonstrate that antibodies interpose themselves between viral particles and the infected cell, forming a chain cluster. Experiments with mutant antibodies subsequently demonstrated that the antibodies’ Y shape creates this clustered structure. Their arms are capable of linking two viruses, or one virus to the infected cell membrane, and their attachment points are sufficiently strong to prompt this phenomenon.

We have demonstrated that only the most powerful antibodies tether viral particles at the surface of infected cells. Trapped viral particles can no longer infect new cells.”


Olivier Schwartz, co-last author of the study and Head of the Virus and Immunity Unit, Institut Pasteur

This work has revealed a new antiviral activity for broadly neutralizing anti-HIV-1 antibodies. It deepens our understanding of these antibodies’ mechanism of action and explains their efficacy in clinical trials. The scientists are now examining antibodies targeting other viruses, including SARS-CoV-2, to determine whether they also inhibit viral spread through this mechanism.

Source:

Journal reference:

Dufloo, J., et al. (2022) Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells. Nature Communications. doi.org/10.1038/s41467-022-28307-7.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

A single gene can control brain cell growth in humans, research shows

A single gene can control brain cell growth in humans, research shows

by Medical Finance
May 13, 2022
0

Controlling how cells grow is fundamental to ensuring proper brain development and stopping aggressive brain tumors. The network of molecules...

Mayo Clinic researchers report differences in genomic data quality among racial groups

Mayo Clinic researchers report differences in genomic data quality among racial groups

by Medical Finance
May 13, 2022
0

Mayo Clinic researchers studied the differences in genomic data quality among racial groups in one of the largest and most...

Higher doses of antibiotics are needed to eliminate infection in a polymicrobial environment

Higher doses of antibiotics are needed to eliminate infection in a polymicrobial environment

by Medical Finance
May 13, 2022
0

A study has found that much higher doses of antibiotics are needed to eliminate a bacterial infection of the airways...

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Researchers identify a gene that could prevent Parkinson’s disease

by Medical Finance
May 13, 2022
0

A UNIGE team has identified a gene whose overexpression prevents the development of Parkinson’s disease in the fruit fly and...

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Two clever human antibodies can target Ebola and Sudan virus

by Medical Finance
May 13, 2022
0

Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives....

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Function of glycolytic enzyme depends on its cellular localization

by Medical Finance
May 13, 2022
0

The function of the glycolytic enzyme hexokinase 1 differs depending on its location within the cell, according to a Northwestern...

Next Post
General Internal Medicine and Geriatrics officially separated into two divisions

General Internal Medicine and Geriatrics officially separated into two divisions

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Researchers pursue a new way to use milk for delivering cancer-fighters to the brain

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: The mechanism of RNA capping by SARS-CoV-2. Image Credit: Design_Cells / Shutterstock
    RNA capping mechanism of SARS-CoV-2 unveiled
  • Anatomy of Human Heart. Liya Graphics 5ac9d64765b747899bc4a9ef77468432 620x480
    Newest federally recognized tribe to open first clinic
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply